University of Florida
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Florida sits in the top decile of US sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count).
University of Florida: 1,106 sponsored US clinical trials, 170 recruiting.
University of Florida sponsors 1,106 registered US clinical trials on ClinicalTrials.gov, 170 of them currently recruiting, and 754 completed. 103 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Coronary Artery Disease, with 17 trials.
Top-decile sponsor footprint
University of Florida ranks in the top decile of sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
754 of 855 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,106 total, page 18 of 23
Study To Analyze Memory/Thinking Problems In Older Adults After Surgery
NCT01786577
Efficacy of Steroid Supplementation After TMJ Rinsing for Pain Management
NCT01770912
13C-Pyruvate Breath Test
NCT01807702
Assessment of Dystussia in Traumatic Brain Injury
NCT02240329
Peroral Endoscopic Myotomy (POEM) for the Treatment of Achalasia
NCT01832779
Pocket Echocardiography System (PES) for Detection of PDA in Neonates
NCT01790750
Dalfampridine and Gait in Spinocerebellar Ataxias
NCT01811706
Pharmacodynamic Effect of Prasugrel vs. Ticagrelor in Diabetes
NCT01852214
Alveolar Microperforation for Inflammation-Enhanced Tooth Movement During Orthodontic Treatment
NCT01720797
Occupational Therapy Driving Intervention for Returning Combat Veterans.
NCT02764983
Impact of Ticagrelor Re-load on Pharmacodynamic Profiles
NCT01731041
Hypoxia Inducible Factor 1 Alpha as a Novel Biomarker in Septic Shock
NCT02163473
The Role of Non-Alcoholic Fatty Liver Disease in Gestational Diabetes
NCT01855386
Clinical Trial to Reduce Drinking in Women With HIV
NCT01625091
Identify Clinical Conditions That Increase Circulating DNA Levels
NCT01815996
Study of a Multimodality Pain Management Protocol on Postoperative Neurosurgical Pain
NCT01693588
My Lifestyle Intervention of Food and Exercise
NCT01630499
Cranberry Consumption Improves γδ T Cell Function
NCT01713829
Oral Alkali Production and Caries Prevention in Children (Longitudinal)
NCT02398695
The Effect of Probiotics (L. Helveticus, B. Longum, and B. Bifidum) on Immune Function and Digestive Health
NCT01709825
Insights Into Deep Brain Stimulation (DBS) for Cervical Dystonia
NCT01671527
Central Mechanisms of Intervention for Low Back Pain
NCT01406847
Phase II Study of 5-FU, Oxaliplatin Plus Dasatinib in Metastatic Pancreatic Adenocarcinoma
NCT01652976
Evaluation of Bacillus Subtilis R0179 in Healthy Young Adults
NCT01802151
Probiotics (L. Gasseri, B. Bifidum, B. Longum) on Immune and Intestinal Health in Healthy Older Adults
NCT01662206
Endoscopic Ultrasound-Guided Fiducial Placement for Stereotactic Body Radiotherapy
NCT01671163
Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01)
NCT01987193
Evaluation of the Texas Wellness Incentives and Navigation (WIN) Project
NCT02440906
Periodontal Treatment Response in Type II Diabetic Patients
NCT01881074
Can Short Latency Afferent Inhibition Give us Clues to Better DYT 1 Dystonia Treatments?
NCT01435681
Clinical Study to Evaluate the Role of Microdialysis for the Comparison of Topical Products
NCT01592019
Proton Therapy for Lymph Nodes in Breast Cancer
NCT01365845
Tolvaptan for Ascites in Cirrhotic Patients
NCT01292304
Pharmacodynamic Effects of Dabigatran in Patients on Dual Antiplatelet Therapy
NCT01852162
Pharmacodynamic Effects of Prasugrel Compared With Ticagrelor in Patients With Coronary Artery Disease
NCT01852175
Laparoscopy-assisted ERCP in Patients With Altered Gastric Anatome
NCT01620632
Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer (SCLC)
NCT01487499
Sorafenib Plus Capecitabine (SorCape) in Previously Treated Metastatic Colorectal Cancer
NCT01471353
Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching
NCT01494896
Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer
NCT01553019
Immune Benefits From Mushroom Consumption
NCT01398176
Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic Adenocarcinoma
NCT01470417
Ampicillin for DYT-1 Dystonia Motor Symptoms
NCT01433757
Peak Impact Forces and Metabolic Cost During Mid-Forefoot Striking in Shod Versus Barefoot Runners
NCT01536171
Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer
NCT01368055
The Effect of Fiber Snack Foods on Dietary Intake in Healthy Adults
NCT01478659
Pharmacotoxicology of Trichloroethylene Metabolites
NCT00865514
Investigations of Botanicals on Food Intake, Satiety, Weight Loss, and Oxidative Stress
NCT01238887
Effect of Apidra Compared to Humalog in Decreasing Post-Prandial Hyperglycemia
NCT01621776
Genetic Contribution of Pain and Inflammation in IBS
NCT01436760
What is open in the University of Florida pipeline
170 recruiting of 1,106 indexed (15% open); 754 completed (68%).
Phase mix: 103 late (III/IV) vs 232 early (I/II) (early-phase heavy).
Top condition: Coronary Artery Disease (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Florida: open-pipeline peers nationwide
Peers matched on 1,106 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Florida sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,106 trials (± recruiting share)
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
- Bronx VA Medical Center · 15% recruiting · 13 trials
- Candel Therapeutics · 15% recruiting · 13 trials
Related
What to do with this University of Florida page
1,106 registered trials is a research-attention snapshot, not an endorsement of University of Florida or any single study.
- 170 of University of Florida's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Coronary Artery Disease is the condition University of Florida studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Coronary Artery Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Florida pipeline card: 1,106 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.